2020
DOI: 10.1111/jdv.16496
|View full text |Cite
|
Sign up to set email alerts
|

Color Doppler ultrasound: a standard of care in hidradenitis suppurativa

Abstract: Immunoblot analysis of cell lysates from transfected HaCaT cells showed no significant difference in the levels of Flag-K14 expression from all the plasmids (Fig. 2a). Next, we performed immunofluorescence analysis using antibodies against Flag and K5. Flag-K14WT formed network structures that colocalized with endogenous K5 (Fig. 2b), indicating keratin filament dimerization between Flag-K14WT and endogenous K5. In contrast, a part of Flag-K14S281_L284del and Flag-K14N123S did not colocalize with K5. In additi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
15
0
1

Year Published

2020
2020
2023
2023

Publication Types

Select...
8
2

Relationship

2
8

Authors

Journals

citations
Cited by 18 publications
(16 citation statements)
references
References 10 publications
0
15
0
1
Order By: Relevance
“…Robust ex vivo models might corroborate clinical data. 197 Clearer documentation and newer diagnostic techniques, such as standardized photography, ultrasound and thermography 66,[198][199][200]…”
Section: What Are We E Xpec Ting In the Future?mentioning
confidence: 99%
“…Robust ex vivo models might corroborate clinical data. 197 Clearer documentation and newer diagnostic techniques, such as standardized photography, ultrasound and thermography 66,[198][199][200]…”
Section: What Are We E Xpec Ting In the Future?mentioning
confidence: 99%
“…Ultrasound-based staging for HS severity has now been published. [58,59] Ultrasound detection of a variety of subclinical anatomic abnormalities in early patients with HS was discussed; these findings may have an important impact on staging of disease severity as well as management and progression of the disease.…”
Section: Ximena Wortsman Chilementioning
confidence: 99%
“…Future treatment target molecules have been proposed [ 7 ], and experimental human models for in vitro/ex vivo studies of HS are under development [ 8 ]. Visual technology, such as standardised photography, ultrasound and thermography [ 9 , 10 , 11 , 12 ], together with digital technology for patient outcome measures, such as daily digital assessment of pain [ 13 ], have the potential to markedly improve the objective evaluation of HS severity assessment. On the other hand, HS continues to be the skin disease that causes the greatest impairment of quality of life (QoL) [ 14 ] and methods to measure this impairment, although developing, have not yet improved to the extent of other physical aspects of the disease [ 15 , 16 ].…”
Section: Introductionmentioning
confidence: 99%